Trial reportScientific reports2026
The effects of approach bias modification on smoking cue-reactivity in individuals who smoke: A randomized controlled fMRI study.
Trial report in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Approach bias modification (ApBM), a computerized training designed to retrain involuntary approach action tendencies toward drug-related cues, has been shown to reduce relapse rates when added to treatment-as-usual (TAU) in alcohol use disorder. A potential working mechanism involves reduced neural drug cue-reactivity in reward-related brain regions. In smoking cessation, however, the efficacy and neural mechanisms of ApBM remain unclear. In this randomized-controlled trial, individuals with chronic, moderate-to-heavy tobacco dependence (N = 117, Mage = 41.5, 45.3% female) received a one-day smoking cessation intervention (TAU) and were subsequently randomized to complete seven sessions of ApBM (TAU+ApBM), Sham control training (TAU+Sham), or no training (TAU-only). Neural reactivity toward smoking-related versus neutral stimuli (smoking cue-reactivity) was assessed using functional magnetic resonance imaging (fMRI) before and after intervention. Abstinence was the primary clinical outcome. Results showed no significant group×time interactions on cue-reactivity, and ApBM did not enhance abstinence rates. In the precuneus (sensorimotor region), increased cue-reactivity following ApBM was associated with higher long-term abstinence probability, while the control groups showed the opposite descriptive pattern. In conclusion, ApBM did not reduce smoking cue-reactivity in reward-related regions, consistent with the lack of beneficial effects on clinical outcomes. Alternative neural target processes (e.g., sensorimotor-related) and respective training procedures should be explored.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.